glp 1 s peptide GLP-1 for Weight Loss and Diabetes The Quest for Oral GLP-1s

2003 The landmark 2003 study by Molinoff, Shadiack, Earle, Diamond, and Quon published in Annals of the New York Academy of Sciences confirmed that PT-141 administration to normal men and patients with erectile dysfunction produced a rapid, dose-dependent increase in erectile activity establishing the foundational clinical pharmacodynamic data for PT-141s erectile research application and confirming that the CNS melanocortin pathway generates erectile responses independently of peripheral vascular mechanisms

It helps to regulate inflammation, which is a critical component of the immune response

AOD-9604 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use

Diabetes (2001) 50(6):134450